Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials

ClinicalLIVEUpdated 18 Nov 2026

New Clinical Trials

Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.

Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.

Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777

Signals

What the register says this week, and why it matters if you sell into it.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
  3. 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
  4. A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

Export the full new clinical trials

777 rows as a .csv. Free. Every field, with its source link.

Country 1
Phase
Study type
11 / 777 trials
PostedSponsorStudyPhaseStatus
17 Nov 2026AstraZenecaUnited States, Argentina, AustraliaA Study to Investigate the Efficacy and Safety of Dato-DXd-based Combinations in Participants With TROP2 NMR+ NSCLCPhase 2Not Yet Recruiting16 Nov 2026Dr. August Wolff GmbH & Co. KG ArzneimittelBrazilNon-inferiority Study of a Hydroxyapatite and Calcium Hypophosphite Toothpaste Compared With Two Comparator Toothpastes in Dentin HypersensitivityNot applicableRecruiting12 Nov 2026Novo Nordisk A/SUnited States, Argentina, BrazilA Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at Lower Dose Levels in People With Type 2 Diabetes Treated With Metformin, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i), or BothPhase 3Not Yet Recruiting12 Nov 2026Novo Nordisk A/SUnited States, Argentina, AustraliaAMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or BothPhase 3Not Yet Recruiting12 Nov 2026Novo Nordisk A/SUnited States, Brazil, ChinaA Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease Treated With Once Daily Basal Insulin Alone or in Combination With Metformin, SGLT2i, or BothPhase 3Not Yet Recruiting5 Nov 2026Brainfarma Industria Química e Farmacêutica S/ABrazilCosmetic Efficacy Evaluation of Hydraporin AI Cream in Individuals With Atopic Dermatitis and PsoriasisNot applicableNot Yet Recruiting5 Nov 2026Novo Nordisk A/SUnited States, Argentina, AustraliaA Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and ObesityPhase 3Not Yet Recruiting4 Nov 2026Boehringer IngelheimUnited States, Argentina, AustriaA Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)Phase 3Not Yet Recruiting28 Oct 2026Eli Lilly and CompanyUnited States, Argentina, AustraliaA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular RiskPhase 3Not Yet Recruiting27 Oct 2026Swedish Orphan BiovitrumBrazil, Canada, FinlandA Study to Assess the Efficacy and Safety of Pegcetacoplan for the Prevention of Recurrent C3G or Primary IC-MPGN in Kidney Transplant RecipientsPhase 3Recruiting20 Oct 2026AstraZenecaBrazilA Study to Evaluate Treatment Patterns and Investigate Adult Patients With B-cell LymphomaNot Yet Recruiting

// How AOS uses this

Every row here is a potential account. AOS finds the ones that need what you sell, maps the decision makers and prepares the outreach for your approval.